News

Illumina claimed that the kit, which the company has commenced shipping broadly, is the first in a series of new kits that further advance data quality, ease of

With these launches the company plans to expand its product selection in order to offer a more comprehensive range of amino acids. Amino’s current line-up of amino acids

Takepron is a proton pump inhibitor discovered by Takeda Pharmaceutical and has been launched since 1992 in Japan. Takeda Pharmaceutical said that administration of low-dose aspirin for a

XOMA and AVEO said that the milestone payment resulted from AVEO’s recent commencement of AV-299 Phase 2 clinical trial to evaluate its antibody for the treatment of non-small

Cepheid has posted a net loss of $1.8m or $(0.03) per diluted share, for the second quarter of 2010, when compared to revenues of $41.0m and a net

As per the terms of the agreement NovImmune is expected to get an upfront payment and is eligible to receive clinical milestones and royalties on sales. NovImmune said

Oracle claimed that the new solution helps pharmaceutical manufacturers facilitate compliance with emerging electronic pedigree (ePedigree) initiatives and regulatory requirements, reduce business and reputational risk associated with the

iCo Therapeutics said that iCo-007 is designed and discovered by ISIS Pharmaceuticals, iCo-007 is a second-generation antisense drug targeting c-Raf kinase for the treatment of DME and diabetic

Sanofi-aventis said that Lovenox, by nature, is a complex biological product and its efficacy and safety profile relies on the strict adherence to the specific processes applied in